Literature DB >> 16900596

Tyrosine kinase inhibitors: the next generation.

Janet Fricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16900596     DOI： 10.1016/s1470-2045(06)70777-x

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.

Authors:  Adel S El-Azab; Alaa A-M Abdel-Aziz; Hazem A Ghabbour; Manal A Al-Gendy
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

2.  Synthesis and anticancer activity of new quinazoline derivatives.

Authors:  Hatem A Abuelizz; Mohamed Marzouk; Hazem Ghabbour; Rashad Al-Salahi
Journal:  Saudi Pharm J       Date:  2017-04-22       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.